STOCK TITAN

Viatris (VTRS) executive Enrietti exercises RSUs, withholds shares for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Viatris Inc executive Andrew Enrietti reported routine equity compensation activity involving restricted stock units (RSUs), dividend equivalent units (DEUs) and related tax withholding. On March 6, 2026, 19,169 RSUs granted on March 6, 2025 vested and were exercised into 19,169 shares of common stock, and 951.6215 DEUs were likewise exercised into 951.6215 shares.

To cover tax liabilities from these vestings, 8,337 and 415 shares of common stock were withheld at $14.16 per share, which is a non‑market disposition rather than an open‑market sale. After these transactions, Enrietti directly held 219,677 shares of Viatris common stock.

He also received a new award of 60,435 RSUs on March 6, 2026, each representing one share of common stock, scheduled to vest in three equal installments of 20,145 RSUs on March 6 of 2027, 2028 and 2029, in addition to remaining unvested RSUs and associated DEUs from the 2025 grant.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Enrietti Andrew

(Last) (First) (Middle)
1000 MYLAN BOULEVARD

(Street)
CANONSBURG PA 15317

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Viatris Inc [ VTRS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/06/2026 X 19,169 A $0 227,477 D
Common Stock 03/06/2026 F 8,337(1) D $14.16 219,140 D
Common Stock 03/06/2026 X 952(2) A $0 220,092 D
Common Stock 03/06/2026 F 415(3) D $14.16 219,677 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0 03/06/2026 X 19,169 (4) (4) Common Stock 19,169 $0 38,337 D
Dividend Equivalent Units $0 03/06/2026 X 951.6215(5) (6) (6) Common Stock 951.6215 $0 1,903(5) D
Restricted Stock Units $0 03/06/2026 A 60,435 (7) (7) Common Stock 60,435 $0 60,435 D
Explanation of Responses:
1. Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 6, 2025.
2. Fractional shares have been rounded up in connection with the settlement described in footnote 6 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
3. Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025.
4. Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 19,169 of the RSUs granted on March 6, 2025 vested on March 6, 2026, 19,168 will vest on March 6, 2027 and 19,169 will vest on March 6, 2028.
5. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.
6. Represents DEUs that accrued with respect to the RSUs previously granted on March 6, 2025 and vest on the same schedule as the underlying RSUs.
7. Each RSU represents the right to receive one share of common stock of Viatris. 20,145 of the RSUs granted on March 6, 2026 will vest on each of March 6, 2027, March 6, 2028, and March 6, 2029.
Remarks:
Chief Administrative and Transformation Officer
/s/ Kevin Macikowski, by power of attorney 03/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Viatris (VTRS) executive Andrew Enrietti report in this Form 4?

He reported RSU and dividend equivalent unit vesting, related share issuances, tax withholding, and a new RSU grant. These are compensation-related equity transactions, not open‑market stock purchases or sales, and reflect routine use of Viatris’ 2020 Stock Incentive Plan.

How many Viatris (VTRS) shares did Andrew Enrietti acquire through vesting and exercises?

He acquired 19,169 shares of common stock from vested RSUs and 951.6215 shares from vested dividend equivalent units. Each RSU and DEU converted into one share of Viatris common stock upon settlement under previously granted equity awards.

Were any of Andrew Enrietti’s Viatris (VTRS) shares sold on the open market?

No open‑market sales were reported. Shares labeled with code F were withheld by Viatris—8,337 and 415 shares—solely to satisfy tax liabilities tied to RSU and DEU vesting, a standard non‑market tax‑withholding mechanism.

How many Viatris (VTRS) shares does Andrew Enrietti hold after these transactions?

Following the reported activity, he directly holds 219,677 shares of Viatris common stock. This figure reflects post‑transaction ownership after RSU and DEU settlements and the associated tax‑withholding share dispositions.

What new RSU award did Andrew Enrietti receive from Viatris (VTRS)?

He received a grant of 60,435 restricted stock units, each representing one Viatris share. According to the disclosure, 20,145 RSUs will vest on each of March 6, 2027, March 6, 2028, and March 6, 2029, subject to award terms.

What happens to the remaining RSUs and DEUs from Enrietti’s prior Viatris (VTRS) grant?

From the March 6, 2025 RSU grant, 19,168 RSUs vest on March 6, 2027 and 19,169 on March 6, 2028. Related dividend equivalent units accrue and vest on the same schedule, providing additional shares when those installments settle.
Viatris Inc Ord Shs

NASDAQ:VTRS

View VTRS Stock Overview

VTRS Rankings

VTRS Latest News

VTRS Latest SEC Filings

VTRS Stock Data

15.89B
1.15B
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG